Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ALVR

AlloVir (ALVR)

AlloVir Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALVR
DateTimeSourceHeadlineSymbolCompany
05/21/20243:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
05/17/20247:00PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
05/13/20243:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALVRAlloVir Inc
05/07/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
03/14/20245:10AMPR Newswire (US)Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:ALVRAlloVir Inc
03/07/20244:45AMPR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. Lawsuit - ALVRNASDAQ:ALVRAlloVir Inc
02/22/20243:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
02/22/20244:45AMPR Newswire (US)Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:ALVRAlloVir Inc
02/21/20247:22PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
02/20/20244:00PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
02/15/20243:30PMEdgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:ALVRAlloVir Inc
02/12/20243:34PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
02/09/20244:45AMPR Newswire (US)Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:ALVRAlloVir Inc
02/06/20243:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
02/05/20247:00PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
02/02/20244:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of AlloVir, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2024 - (NASDAQ: ALVR)NASDAQ:ALVRAlloVir Inc
01/26/20244:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of AlloVir, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2024 - (NASDAQ: ALVR)NASDAQ:ALVRAlloVir Inc
01/25/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
01/23/20247:30PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
01/09/202411:32AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALVRAlloVir Inc
01/09/202411:29AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ALVRAlloVir Inc
01/08/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
01/05/20245:14AMIH Market NewsWall Street Highlights: Google Rejects Union Negotiations, Exxon Mobil Announces $2.5 Billion Accounting Write-Down in CaliforniaNASDAQ:ALVRAlloVir Inc
01/04/20245:00PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
01/04/20244:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
12/22/20236:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
12/22/20236:00AMGlobeNewswire Inc.AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell TherapyNASDAQ:ALVRAlloVir Inc
11/21/20234:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
11/20/20234:00PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
11/17/20234:30PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
 Showing the most relevant articles for your search:NASDAQ:ALVR